IPO News Archive
Pediatric products supplier Mead Johnson Nutrition files for IPO

9/15/08


Mead Johnson Nutrition, a leading provider of infant formula and other pediatric nutrition products, filed with the SEC for an IPO on Monday. Mead Johnson is a spin-off of pharmaceutical firm Bristol-Myers Squibb and sells formula worldwide under the Enfamil brand. The company booked $2.8 billion in LTM revenues and plans to list its shares on the NYSE under the ticker MJN. Citi and Morgan Stanley are the joint book-running managers on the deal. No terms were disclosed in the initial filing.

View IPO Profile: MJN         
Related Links: Recently Filed IPOs
Source: www.RenaissanceCapital.com
Latest User Comments
Up strong today on very big volume 3/31/2009 8:06:43 PM
Posted by: rosietra
one of the best performing stks in this market....
Sold ( DAC ) 3.76 3/12/2009 3:52:55 PM
Posted by: Stoptrad
Maybe alittle to early to be getting DAC ? So im going to take a little profit and wait for a better rollback..?...
BUY --- ( DAC ) on this rollback.........$$$$ 3/12/2009 2:33:13 PM
Posted by: Stoptrad
I like DRYS, but theres a nice rollback on DAC today..

So pick some up at 3.55..................
Quiet period ending March 22 . . . positive research coming? 3/12/2009 1:12:52 PM
Posted by: billythe
MJN's quiet period is set to end March 22 . . . I'm sure Wall Street research will be positive given the "defensive" nature of its business and the company's strong global brand recognition. The stoc...
A big drop today 2/23/2009 5:58:56 PM
Posted by: polopony
Hope it doesn't test the IPO price...

Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the IPO Plus Fund (symbol: IPOSX) may have investments in securities of companies mentioned.
Invest in the IPO Plus Fund
About Fund Prospectus Invest